RTP firm receives FDA approval for first coronavirus blood test in US

A Triangle life science company has received the first FDA approval for an antibody test for COVID-19, another laurel for the Research Triangle's role in combatting the global pandemic. On Thursday, the U.S. Food and Drug Administration sent a letter to Research Triangle Park-based Cellex issuing it an emergency use authorization (EUA) for its test. The authorization gives the company the ability to manufacture and distribute the product. The test is approved by the agency for use in diagnosing…